Do you have the same question? Follow this Question
Mar 20, 2025 - 01:54 PM
We’ve provided several answers to questions related to Aptiom (Eslicarbazepine acetate) , see some other helpful Q&A related to this product.
Question: What is the primary use of this medication?
Answer: The primary use of this medication is for the treatment of partial-onset seizures. Treating seizures helps improve quality of life by reducing seizure frequency and severity, which can enhance daily functioning and safety.
Question: What is the DrugBank ID for this medication?
Answer: The DrugBank ID for this medication is DB09119. DrugBank provides comprehensive data on drugs and their mechanisms, beneficial for healthcare providers and researchers.
Question: What is the elimination half-life of the medication?
Answer: The elimination half-life of the medication is 10-20 hours. This indicates how long the drug stays active in the body, which is important for determining dosing schedules.
View all Aptiom (Eslicarbazepine acetate) Questions & Answers
